Clinical Trial Update: Mi-iron - Moderately Increased Iron - is Reducing Iron Overload Necessary? [NA]

View source ↗

Summary

A completed clinical trial evaluating Mi-iron for hereditary hemochromatosis to determine whether reducing iron overload is necessary.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Hemochromatosis

Drugs mentioned

• Mi-iron

Snippet

Sponsor: Murdoch Childrens Research Institute | Conditions: Hereditary Haemochromatosis | NA | Status: COMPLETED